Active ingredientLomerizine diHClCat. No. P-L085-001Family · Pharmaceutical analytical standards
Lomerizine
An L-type and T-type calcium channel blocker of the diphenylpiperazine class, used to prevent migraine: small and lipophilic, it crosses the blood-brain barrier. It was first approved in Japan in 1999. This family brings together the active ingredient and other impurities.
Did you know?Its effect against migraine seems to come not so much from blocking calcium channels as from blocking serotonin 5-HT2A receptors; it has also been studied for protecting the retina and the optic nerve.
Go to the active ingredient →Active ingredientLomerizine diHClCat. No. P-L085-001
ImpurityLomerizine Impurity 1Cat. No. P-L085-003
ImpurityLomerizine Impurity 2Cat. No. P-L085-004
ImpurityLomerizine Impurity 3Cat. No. P-L085-005No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.